A new drug promising to relieve symptoms of irritable bowel syndrome (IBS) is being trialled in the UK.
The pill — named Blautix — which is said to “soak up rotten egg gas” is currently being tested in Manchester.
Two in 10 people suffer from IBS in the UK, with symptoms including stomach cramps, bloating, diarrhoea and constipation.
But the new pill is thought to reduce — and even have the ability to get rid of — bloating, flatulence and diarrhoea.
Despite the exact cause for IBS is still unknown, experts claim that hydrogen sulphide causes stomach to pump out gas, causing the uncomfortable symptoms.
Blautix contains blautia hydrogenotrophica, a bacterium that removes hydrogen from the intestines.
Developers of the drug claim that 82 per cent of patients that have taken the medication have found their symptoms have improved.
Following the findings being presented at the Digestive Disease Week conference held in Washington, the drug is being trialled in Wythenshawe Hospital, the first institution in the UK to test the pill. It is also being trialled in medical centres throughout the US and Europe.
Participants in the trial will take the capsules for three months, giving blood, urine and stool samples so scientists can analyse if their symptoms have improved.
Consultant gastroenterologist Dr Jason Dunn told The Sun: “Recent research suggests patients with IBS do have altered gut microbiota compared to people with healthy digestion.
"Studies in those with IBS have shown proportions of specific bacterial groups are altered. Biodiversity is also reduced.
"So there is great interest in treatments like this to modulate the microbiota, though the current evidence that these are effective in improving symptoms remains limited."
Source: Read Full Article